Filing Details
- Accession Number:
- 0001140361-12-028057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-31 17:11:50
- Reporting Period:
- 2012-05-30
- Filing Date:
- 2012-05-31
- Accepted Time:
- 2012-05-31 17:11:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 69499 | Mylan Inc. | MYL | Pharmaceutical Preparations (2834) | 251211621 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197539 | L Randall Vanderveen | 1500 Corporate Drive Canonsburg PA 15317 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-05-30 | 67,500 | $14.12 | 89,728 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-05-30 | 67,500 | $21.53 | 22,228 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-05-30 | 22,500 | $13.19 | 44,728 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-05-30 | 22,500 | $21.53 | 22,228 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option Right to Buy | Acquisiton | 2012-05-30 | 67,500 | $0.00 | 67,500 | $14.12 |
| Common Stock | Stock Option Right to Buy | Acquisiton | 2012-05-30 | 22,500 | $0.00 | 22,500 | $13.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2003-06-20 | 2012-06-20 | No | 4 | M | Direct |
| 0 | 2003-07-26 | 2012-07-26 | No | 4 | M | Direct |
Footnotes
- As disclosed in the Company's Form 10-Q for the quarter ended September 30, 2011, Mr. Vanderveen's stock options were among those held by directors that were set to expire in 2012.
- Represents the weighted price of the reporting person's disposition of 90,000 shares in transactions ranging from $21.50 to $21.60.
Billionaire Hedge Funds
